Skip to main content
. 2015 Dec 29;12(3):238–242. doi: 10.11138/ccmbm/2015.12.3.238

Table 2.

Serum concentrations of 25-hydroxyvitamin D [25 (OH) D].

25 (OH) D Patients with acne vulgaris (n=39) Healthy controls (n=40) P-value
25 (OH) D, ng/mL 8.4 (1.4–99); (5–14.1) 10.4 (3.1–56.7); (6.58–20.25) 0.14
25 (OH) D categories#, no. (%)
Severe vitamin D deficiency 24 (61.5%) 20 (50.0%)
Moderate vitamin D deficiency 9 (23.1%) 10 (25%)
Vitamin D insufficiency 2 (5.1%) 6 (15%)
Vitamin D sufficiency 4 (10.3%) 4 (10%)
Sun-exposure time
 < 2 hours per day 8.25 (1.4–99); (4.05–14.62) 10.4 (3.1–56.7); (6.58–20.08)
 ≥ 2 hours per day 8.5 (3.3–22.2); (7.7–14.1) 13.5 (5.5–21); (6–20.62)
GAGS* -
 Mild (n=12) 8.45 (1.7–34.6); (3.08–16.35)
 Moderate (n=17) 8.6 (1.4–99); (7.2–21.3)
 Severe/very severe(n=10) 7.05 (3.3–12.8); (3.7–10.3)

Values are median (range); IQR of serum 25-hydroxyvitamin D, unless otherwise stated.

Abbreviations: IQR, Interquartile range (25th–75th percentiles); GAGS: Global Acne Grading System

#

Subjects were divided into four categories: Severe vitamin D deficiency [25(OH)D <10 ng/ml], moderate vitamin D deficiency [25(OH)D 10 to <20 ng/ml], vitamin D insufficiency [25(OH)D 20 to <30 ng/ml] and vitamin D sufficiency [25(OH)D≥30 ng/ml]

*

A GAGS score of 1–18 is considered mild; 19–30, moderate; 31–38, severe; and >39, very severe